Robert D. Dowling
YOU?
Author Swipe
View article: Mitral Annular Calcification: Natural History, Prognosis, and Clinical Outcomes
Mitral Annular Calcification: Natural History, Prognosis, and Clinical Outcomes Open
Ten percent of patients with MAC have clinically significant MVD, with mitral regurgitation being more common than mitral stenosis. The presence of MVD is associated with significantly increased mortality in patients with MAC.
View article: Repeat Interventions After Transcatheter Aortic Valve Replacement: Clinical Characteristics and Outcomes of Redo Transcatheter Aortic Valve Replacement and Surgical Explants
Repeat Interventions After Transcatheter Aortic Valve Replacement: Clinical Characteristics and Outcomes of Redo Transcatheter Aortic Valve Replacement and Surgical Explants Open
Repeat interventions are uncommon in the first decade after TAVR. In clinical practice, the mechanism of failure of the TAVR valve is an important determinant of subsequent treatment; most patients with structural valve deterioration recei…
View article: Use of Intravascular Micro-Axial Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock: Mid-Term Outcomes
Use of Intravascular Micro-Axial Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock: Mid-Term Outcomes Open
Objectives: Patients in cardiogenic shock (CS) may be successfully bridged using intravascular micro-axial left ventricular assist devices (M-LVADs) for recovery or determination of definitive therapy. Methods: One hundred and seven CS pat…
View article: Use of Intravascular Micro-Axial Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock: Mid-Term Outcomes
Use of Intravascular Micro-Axial Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock: Mid-Term Outcomes Open
Objectives: Cardiogenic shock [CS] is associated with a high-mortality. Suitable patients maybe successfully bridged using newer intravascular micro-axial left-ventricular assist devices [M-LVAD] for recovery or determination of definitive…
View article: Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study
Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study Open
In patients with SAA, we observed no difference in mortality between SEV and BEV up to 3 years after the index procedure, despite early differences in valve hemodynamics.
View article: OR7-7 | Repeat Intervention after Transcatheter Aortic Valve Replacement: Clinical Characteristics and Outcomes of Redo Transcatheter Aortic Valve Replacement and Surgical Explant
OR7-7 | Repeat Intervention after Transcatheter Aortic Valve Replacement: Clinical Characteristics and Outcomes of Redo Transcatheter Aortic Valve Replacement and Surgical Explant Open
Transcatheteraortic valves (TAV) are subject to degeneration and repeat intervention. TAV are increasingly used in clinical practice but there is paucity of data regarding repeat interventions. We sought to describe and compare clinical ch…
View article: Long‐term post‐transplantation outcomes in patients with hypertrophic cardiomyopathy: Single‐center 35‐year experience
Long‐term post‐transplantation outcomes in patients with hypertrophic cardiomyopathy: Single‐center 35‐year experience Open
Background Heart transplantation (HT) is the only option for most patients with end‐stage heart failure and hypertrophic cardiomyopathy (HCM) who fail medical therapy. Data on the long‐term outcomes post‐transplant in HCM individuals remai…
View article: Erratum to “J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device”[Journal of the Society for Cardiovascular Angiography & Intervention 2 (2023) 101044]
Erratum to “J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device”[Journal of the Society for Cardiovascular Angiography & Intervention 2 (2023) 101044] Open
J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist DeviceJournal of the Society for Cardiovascular Angiography & InterventionsVol. 2Issue 4101044PreviewThe use of left ventricular…
View article: J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device
J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device Open
The use of left ventricular assist devices (LVAD) has expanded rapidly for both destination therapy and as a bridge to transplant.1Kirklin J.K. Naftel D.C. Pagani F.D. et al.Seventh INTERMACS annual report: 15,000 patients and counting.J H…
View article: Enhanced Left Ventricular Recovery in Treatment of Mitral Regurgitation With Severe Left Ventricular Dysfunction
Enhanced Left Ventricular Recovery in Treatment of Mitral Regurgitation With Severe Left Ventricular Dysfunction Open
A 73-year-old male patient presented with shortness of breath at rest resulting from new-onset severe primary mitral regurgitation with a flail posterior leaflet, left ventricular dysfunction, and cardiogenic shock. After initial stabiliza…
View article: One‐year follow‐up results from AUGMENT‐HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure
One‐year follow‐up results from AUGMENT‐HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure Open
Aims AUGMENT‐HF was an international, multicentre, prospective, open‐label, randomized, controlled evaluation testing the hypothesis that Algisyl (injectable calcium alginate hydrogel) is superior to standard medical therapy ( SMT ) for im…
View article: A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial) Open
NCT01311791.